Valuation (19%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 78.57 | N/A |
| PEG Ratio (TTM) | -1.22 | N/A |
| P/S Ratio (TTM) | 34.93 | N/A |
| P/B Ratio (TTM) | 4.10 | N/A |
| P/FCF Ratio (TTM) | -32.34 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.56% | N/A |
| ROE (TTM) | 1.55% | N/A |
| Net Profit Margin (TTM) | 52.24% | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -168.86% | N/A | N/A |
| Revenue | -25.00% | N/A | N/A |
| Net Income | -128.73% | N/A | N/A |
| Cash Flow | -10.51% | N/A | N/A |
Health (26%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.07 | N/A |
| Quick Ratio (TTM) | 0.07 | N/A |
| D/E Ratio (TTM) | 0.06 | N/A |
| Interest Coverage (TTM) | -1.30 | N/A |
| Piotroski F-Score | 3 | N/A |
| Altman Z-Score | 0.26 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |